Chimera Investment Stock Forecast, Price & News

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Chimera Investment in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Chimera Investment stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CIM, but not buy additional shares or sell existing shares.
View analyst ratings for Chimera Investment or view top-rated stocks.

Wall Street analysts have given Chimera Investment a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Chimera Investment wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Chimera Investment saw a increase in short interest in the month of May. As of May 28th, there was short interest totaling 5,920,000 shares, an increase of 24.6% from the May 13th total of 4,750,000 shares. Based on an average daily volume of 1,930,000 shares, the days-to-cover ratio is presently 3.1 days. Currently, 2.6% of the company's shares are sold short.
View Chimera Investment's Short Interest.

Chimera Investment is scheduled to release its next quarterly earnings announcement on Wednesday, August 4th 2021.
View our earnings forecast for Chimera Investment.

Chimera Investment Co. (NYSE:CIM) announced its quarterly earnings data on Wednesday, May, 5th. The real estate investment trust reported $0.36 earnings per share for the quarter, topping analysts' consensus estimates of $0.30 by $0.06. The real estate investment trust earned $135.06 million during the quarter, compared to analyst estimates of $119.06 million. Chimera Investment had a net margin of 61.53% and a trailing twelve-month return on equity of 10.24%. The firm's revenue for the quarter was down 14.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.56 earnings per share.
View Chimera Investment's earnings history.

Chimera Investment's stock was trading at $18.36 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CIM shares have decreased by 19.0% and is now trading at $14.87.
View which stocks have been most impacted by COVID-19.

Chimera Investment declared a quarterly dividend on Wednesday, May 5th. Shareholders of record on Wednesday, June 30th will be given a dividend of $0.33 per share on Friday, July 30th. This represents a $1.32 annualized dividend and a dividend yield of 8.88%. The ex-dividend date of this dividend is Tuesday, June 29th. This is a boost from Chimera Investment's previous quarterly dividend of $0.30.
View Chimera Investment's dividend history.

Chimera Investment pays an annual dividend of $1.20 per share and currently has a dividend yield of 7.74%. CIM has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Chimera Investment does not yet have a strong track record of dividend growth. The dividend payout ratio of Chimera Investment is 82.19%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, Chimera Investment will have a dividend payout ratio of 75.47% in the coming year. This indicates that Chimera Investment may not be able to sustain their current dividend.
View Chimera Investment's dividend history.

4 equities research analysts have issued twelve-month price targets for Chimera Investment's shares. Their forecasts range from $10.00 to $10.00. On average, they anticipate Chimera Investment's share price to reach $10.00 in the next twelve months. This suggests that the stock has a possible downside of 32.8%.
View analysts' price targets for Chimera Investment or view top-rated stocks among Wall Street analysts.

3 employees have rated Chimera Investment CEO Matthew Lambiase on Glassdoor.com. Matthew Lambiase has an approval rating of 100% among Chimera Investment's employees. This puts Matthew Lambiase in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Chimera Investment include Annaly Capital Management (NLY), AGNC Investment (AGNC), Starwood Property Trust (STWD), Colony Capital (CLNY), Apollo Commercial Real Estate Finance (ARI), Two Harbors Investment (TWO), MFA Financial (MFA), PennyMac Mortgage Investment Trust (PMT), New York Mortgage Trust (NYMT), Redwood Trust (RWT), Ready Capital (RC), Invesco Mortgage Capital (IVR), ARMOUR Residential REIT (ARR), Ares Commercial Real Estate (ACRE) and Capstead Mortgage (CMO).
View all of CIM's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Chimera Investment investors own include New Residential Investment (NRZ), Annaly Capital Management (NLY), Marathon Oil (MRO), AGNC Investment (AGNC), Energy Transfer (ET), AT&T (T), ARMOUR Residential REIT (ARR), New York Mortgage Trust (NYMT), Enterprise Products Partners (EPD) and NGL Energy Partners (NGL).

Chimera Investment trades on the New York Stock Exchange (NYSE) under the ticker symbol "CIM."

Chimera Investment's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (8.56%), Geode Capital Management LLC (1.45%), Northern Trust Corp (1.06%), Mirae Asset Global Investments Co. Ltd. (0.88%), LSV Asset Management (0.81%) and West Family Investments Inc. (0.71%). Company insiders that own Chimera Investment stock include Choudhary Yarlagadda, Matthew Lambiase, Paul Donlin, Phillip John Kardis II and Robert S Colligan.
View institutional ownership trends for Chimera Investment.

CIM stock was sold by a variety of institutional investors in the last quarter, including Arrowstreet Capital Limited Partnership, Goldman Sachs Group Inc., D. E. Shaw & Co. Inc., Victory Capital Management Inc., Northern Trust Corp, Kovack Advisors Inc., Morgan Stanley, and Allianz Asset Management GmbH.
View insider buying and selling activity for Chimera Investment or view top insider-selling stocks.

CIM stock was bought by a variety of institutional investors in the last quarter, including Capital Advisors Inc. OK, GP Brinson Investments LLC, Royal Bank of Canada, JPMorgan Chase & Co., BlackRock Inc., Mirae Asset Global Investments Co. Ltd., Thrivent Financial for Lutherans, and Geode Capital Management LLC. Company insiders that have bought Chimera Investment stock in the last two years include Choudhary Yarlagadda, Matthew Lambiase, Paul Donlin, Phillip John Kardis II, and Robert S Colligan.
View insider buying and selling activity for Chimera Investment or or view top insider-buying stocks.

Shares of CIM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CIM stock can currently be purchased for approximately $14.87.

Chimera Investment has a market capitalization of $3.43 billion and generates $1.03 billion in revenue each year. The real estate investment trust earns $88.85 million in net income (profit) each year or $1.46 on an earnings per share basis.

Chimera Investment employs 41 workers across the globe.

The official website for Chimera Investment is www.chimerareit.com.

Chimera Investment is headquartered at 520 MADISON AVENUE 32ND FLOOR, NEW YORK NY, 10022.

Chimera Investment's mailing address is 520 MADISON AVENUE 32ND FLOOR, NEW YORK NY, 10022. The real estate investment trust can be reached via phone at 212-626-2300 or via email at [email protected]